I’m honored to be speaking at two leading international conferences in aesthetic and reconstructive medicine in early 2026.

6th SCAR Treatment Conference

Milan, Italy · January 2026

I will join global experts at the 6th SCAR Treatment Conference in Milan, focusing on advanced approaches to scar management, innovation in treatment strategies, and clinical outcomes.

Paris, France · January 2026 IMCAS World Congress

Later that month, I will be speaking at IMCAS World Congress 2026 in Paris, one of the world’s most influential congresses in aesthetic medicine and surgery. My lectures will explore forward-thinking concepts, clinical experience, and the future direction of aesthetic and reconstructive treatments.

...

Prof. Yaron Har-Shai participated as an invited speaker at the prestigious SCAR UPDATE 2025, an international symposium hosted by ACSI and DASIL, dedicated to advancing the science and treatment of scars, keloids, and post-traumatic skin conditions.

In Session 1: "Keloids Uncovered", Prof. Har-Shai presented a lecture on:

“Intralesional Cryosurgery for the Treatment of Different Types of Auricular Keloids”

This session explored cutting-edge strategies in both medical and procedural approaches to keloid management. Prof. Har-Shai’s presentation highlighted long-term clinical outcomes and innovative applications of cryosurgery in complex keloid cases.

The event brought together global leaders in dermatologic and surgical scar management, and Prof. Har-Shai’s contribution reflected his ongoing leadership in the treatment of hypertrophic scars and keloids.

Looking ahead, Prof. Har-Shai will also be an invited speaker and faculty at Scars 2026, scheduled to take place at January 16-18, 2026, in Milan, Italy. This annual meeting brings together top-tier experts to share the latest innovations and research in scar prevention and treatmen

For More Information: Scars 2026...

Look at the latest presentation on Intralesional Cryosurgery (CryoShape) for the treatment of hypertrophic scars and keloids: Application versatility, diversity and overlong clinical results up to 20 years....